Explain this page
Arphra AIPlain-English read on Nucor Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +30.22% | +30.12% | +22.51% | +13.35% | +11.93% | +15.97% | +16.21% | +15.73% | +16.40% |
| Operating margin | +25.54% | +25.31% | +17.95% | +9.69% | +8.18% | +12.13% | +11.76% | +12.01% | +12.21% |
| EBITDA margin | +28.04% | +27.87% | +22.15% | +14.60% | +12.64% | +16.46% | +16.48% | +16.83% | +16.88% |
| EBIT margin | +25.67% | +25.31% | +18.78% | +10.18% | +8.08% | +12.24% | +12.71% | +11.99% | +12.50% |
| Pre-tax margin | +25.22% | +24.68% | +18.07% | +9.44% | +7.90% | +11.58% | +12.05% | +11.48% | +12.01% |
| Net margin | +18.71% | +18.33% | +13.03% | +6.60% | +5.37% | +8.37% | +8.25% | +8.57% | +8.13% |
| Cost structure | |||||||||
| Cost of revenue / sales | +69.78% | +69.88% | +77.49% | +86.65% | +88.07% | +84.54% | +86.05% | +83.69% | +84.50% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +4.68% | +4.81% | +4.57% | +3.65% | +3.75% | +4.10% | +4.09% | +3.95% | +3.92% |
| Effective tax rate | +22.59% | +21.13% | +21.68% | +20.09% | +20.64% | +21.24% | +20.38% | +20.95% | +20.18% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +46.75% | +38.87% | +20.45% | +9.46% | +7.88% | +12.63% | +11.94% | +12.91% | +12.07% |
| Return on assets (ROA) | +26.44% | +23.42% | +12.80% | +5.97% | +4.97% | +7.81% | +7.84% | +8.19% | +7.62% |
| Return on capital (ROC) | +45.93% | +40.01% | +21.51% | +10.50% | +9.09% | +13.77% | +12.91% | +13.63% | +13.81% |
| Return on invested capital (ROIC) | +33.65% | +28.97% | +15.62% | +7.15% | +5.96% | +9.50% | +9.06% | +9.73% | +9.19% |
| Asset turnover | +141.28% | +127.81% | +98.23% | +90.55% | +92.56% | +93.36% | +95.08% | +95.53% | +93.77% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +18.71% | +18.33% | +13.03% | +6.60% | +5.37% | +8.37% | +8.25% | +8.57% | +8.13% |
| Asset turnover (× revenue / assets) | +141.28% | +127.81% | +98.23% | +90.55% | +92.56% | +93.36% | +95.08% | +95.53% | +93.77% |
| Equity multiplier (× assets / equity) | +176.82% | +165.97% | +159.74% | +158.47% | +158.67% | +161.76% | +152.34% | +157.68% | +158.35% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 1.41 | 1.28 | 0.98 | 0.91 | 0.93 | 0.93 | 0.95 | 0.96 | 0.94 |
| Fixed-asset turnover | 4.50 | 4.32 | 3.14 | 2.32 | 2.12 | — | — | — | — |
| Inventory turnover | 4.24 | 5.32 | 4.82 | 5.22 | 5.24 | — | — | — | — |
| Receivables turnover | 9.47 | 11.56 | 11.76 | 11.49 | 10.47 | — | — | — | — |
| Payables turnover | 13.91 | 17.59 | 13.32 | 14.54 | 15.14 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 38.56 | 31.57 | 31.05 | 31.77 | 34.88 | — | — | — | — |
| Days inventory outstanding (DIO) | 86.18 | 68.62 | 75.69 | 69.98 | 69.67 | — | — | — | — |
| Days payables outstanding (DPO) | 26.24 | 20.75 | 27.41 | 25.11 | 24.11 | — | — | — | — |
| Cash conversion cycle | 98.50 | 79.44 | 79.33 | 76.64 | 80.44 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 0.91 | 1.32 | 1.57 | 1.96 | 1.85 | 1.75 | 1.78 | 1.69 | 1.75 |
| FCF / Net income | 0.68 | 1.07 | 1.08 | 0.40 | -0.11 | 0.66 | 0.64 | 0.64 | 0.67 |
| FCF margin | +12.63% | +19.57% | +14.11% | +2.62% | -0.58% | +5.52% | +5.24% | +5.46% | +5.42% |
| OCF margin | +17.08% | +24.26% | +20.49% | +12.95% | +9.95% | +14.66% | +14.69% | +14.45% | +14.25% |
| CapEx / Revenue | +4.45% | +4.69% | +6.38% | +10.32% | +10.53% | +9.25% | +9.24% | +9.31% | +9.19% |
| CapEx / D&A | 1.88 | 1.83 | 1.89 | 2.34 | 2.31 | — | — | — | — |
| Stock-based comp / Revenue | +0.37% | +0.33% | +0.37% | +0.43% | +0.41% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 23.16 | 28.79 | 18.00 | 8.46 | 7.52 | 14.48 | 16.00 | 16.61 | 15.78 |
| EPS · basic | 23.23 | 28.88 | 18.05 | 8.47 | 7.53 | 14.54 | 16.17 | 16.43 | 15.89 |
| Book value / share | 49.78 | 74.36 | 88.35 | 89.80 | 95.82 | 108.47 | 117.34 | 114.44 | 118.49 |
| Tangible BV / share | 36.38 | 46.84 | 60.08 | 58.68 | 64.73 | 108.47 | 117.34 | 114.44 | 118.49 |
| Sales / share | 124.35 | 157.73 | 138.63 | 128.86 | 140.73 | 163.81 | 169.96 | 172.38 | 175.94 |
| Operating CF / share | 21.24 | 38.27 | 28.40 | 16.68 | 14.01 | 24.02 | 24.97 | 24.91 | 25.07 |
| Free cash flow / share | 15.71 | 30.87 | 19.56 | 3.38 | -0.81 | 9.04 | 8.91 | 9.42 | 9.53 |
| Dividends / share | 1.65 | 2.03 | 2.06 | 2.19 | 2.22 | 2.60 | 2.75 | 2.75 | 2.77 |
| Payout ratio | +7.08% | +7.02% | +11.38% | +25.75% | +29.36% | +18.99% | +19.61% | +18.58% | +19.40% |
| Retention ratio | +92.92% | +92.98% | +88.62% | +74.25% | +70.64% | +81.01% | +80.39% | +81.42% | +80.60% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +13.78% | -16.38% | -11.47% | +5.73% | +16.60% | +2.64% | +1.63% | +2.64% | +1.33% |
| Gross profit · YoY | — | +13.40% | -37.50% | -47.51% | -5.46% | +56.07% | +4.17% | -1.38% | +7.03% | -6.12% |
| Profit | ||||||||||
| Operating income · YoY | — | +12.74% | -40.70% | -52.18% | -10.74% | +72.91% | -0.55% | +3.80% | +4.38% | -7.59% |
| EBITDA · YoY | — | +13.10% | -33.54% | -41.65% | -8.45% | +51.87% | +2.77% | +3.78% | +2.93% | -4.89% |
| Net income · YoY | — | +11.42% | -40.52% | -55.20% | -13.96% | +81.74% | +1.18% | +5.63% | -2.69% | -8.70% |
| Operating | ||||||||||
| EBIT · YoY | — | +12.20% | -37.95% | -51.99% | -16.07% | +76.53% | +6.60% | -4.14% | +7.03% | -7.38% |
| R&D · YoY | — | — | — | — | — | — | — | — | — | — |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +24.31% | -37.48% | -53.00% | -11.11% | +92.58% | +10.49% | +3.80% | -5.01% | -4.68% |
| EPS · basic · YoY | — | +24.32% | -37.50% | -53.07% | -11.10% | +93.08% | +11.21% | +1.59% | -3.27% | -4.64% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $5.68B | $6.69B | $6.84B | $6.95B | $7.12B | $8.29B | $8.56B | $8.58B | $8.54B |
| Net debt | $3.32B | $2.41B | $459M | $3.39B | $4.86B | $3.61B | $3.77B | $3.75B | $3.4B |
| Net debt / EBITDA | 0.32 | 0.21 | 0.06 | 0.76 | 1.18 | 0.58 | 0.59 | 0.56 | 0.50 |
| Debt / equity | 0.39 | 0.34 | 0.31 | 0.32 | 0.32 | 0.33 | 0.32 | 0.33 | 0.31 |
| Debt / assets | +22.01% | +20.60% | +19.36% | +20.48% | +20.29% | +20.43% | +20.92% | +20.74% | +19.74% |
| Equity / assets | +56.55% | +60.25% | +62.60% | +63.10% | +63.02% | +61.82% | +65.64% | +63.42% | +63.15% |
| Coverage | |||||||||
| EBITDA / interest expense | 62.71 | 52.84 | 31.25 | 19.68 | 69.61 | 30.56 | 31.07 | 30.80 | 31.82 |
| Operating income / interest | 57.13 | 47.99 | 25.33 | 13.07 | 45.07 | 22.52 | 22.16 | 21.97 | 23.02 |
| Interest expense | $163.12M | $218.91M | $246M | $228M | $59M | $204.12M | $206.32M | $216M | $215.23M |
| Liquidity | |||||||||
| Current ratio | 2.48 | 3.39 | 3.57 | 2.51 | 2.94 | — | — | — | — |
| Quick ratio | 1.25 | 1.95 | 2.19 | 1.37 | 1.45 | — | — | — | — |
| Cash ratio | 0.46 | 0.99 | 1.39 | 0.71 | 0.56 | — | — | — | — |
| Working capital | $7.64B | $10.36B | $11.79B | $7.5B | $7.76B | — | — | — | — |
| Working capital / revenue | +20.95% | +24.96% | +33.97% | +24.40% | +23.88% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).